Gambaran Umum
Nxera Pharma Co., Ltd., headquartered in South Korea, operates primarily within the pharmaceutical industry, focusing on the research, development, and manufacturing of innovative drug solutions. The company has carved a niche in developing treatments that address unmet medical needs in various therapeutic areas, including oncology and neurology. Key projects include the advancement of proprietary drug delivery systems and the progression of a pipeline featuring specialized biologic drugs aimed at enhancing treatment efficacy and reducing side effects. Nxera Pharma's strategic initiatives reflect its commitment to leveraging cutting-edge science to improve patient care and outcomes, positioning the company as a progressive player in the global pharmaceutical market.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Nxera Pharma Co., Ltd. per 2025 Jun 30 adalah 31,209.00 MM.
- Nilai operating income untuk Nxera Pharma Co., Ltd. per 2025 Jun 30 adalah -5,726.00 MM.
- Nilai net income untuk Nxera Pharma Co., Ltd. per 2025 Jun 30 adalah -3,272.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 31,209.00 | -5,726.00 | -3,272.00 |
| 2025-03-31 | 30,868.00 | -4,540.00 | -2,317.00 |
| 2024-12-31 | 28,835.00 | -6,624.00 | -4,838.00 |
| 2024-09-30 | 29,275.00 | -1,305.00 | -3,711.00 |
| 2024-06-30 | 23,340.00 | -9,885.00 | -9,836.00 |
| 2024-03-31 | 16,434.00 | -11,511.00 | -9,072.00 |
| 2023-12-31 | 12,766.00 | -10,399.00 | -7,193.00 |
| 2023-09-30 | 12,402.00 | -4,565.00 | -3,378.00 |
| 2023-06-30 | 15,258.00 | 2,448.00 | 1,860.00 |
| 2023-03-31 | 15,393.00 | 3,054.00 | 1,050.00 |
| 2022-12-31 | 15,569.00 | 2,812.00 | 382.00 |
| 2022-09-30 | 22,763.00 | 10,520.00 | -383.00 |
| 2022-06-30 | 17,046.00 | 4,955.00 | -224.00 |
| 2022-03-31 | 17,624.00 | 5,942.00 | 100.00 |
| 2021-12-31 | 17,712.00 | 6,910.00 | 1,017.00 |
| 2021-09-30 | 7,989.00 | -2,154.00 | 1,296.00 |
| 2021-06-30 | 9,449.00 | 141.00 | 1,299.00 |
| 2021-03-31 | 8,887.00 | 61.00 | 1,072.00 |
| 2020-12-31 | 8,842.00 | 854.00 | 1,479.00 |
| 2020-09-30 | 6,399.00 | -1,351.00 | -1,671.00 |
| 2020-06-30 | |||
| 2020-03-31 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | -53.92 | -53.92 |
| 2024-09-30 | -42.09 | -42.09 |
| 2024-06-30 | -113.99 | -113.99 |
| 2024-03-31 | -107.49 | -107.50 |
| 2023-12-31 | -87.17 | -87.18 |
| 2023-09-30 | -41.16 | -41.15 |
| 2023-06-30 | 22.69 | 22.45 |
| 2023-03-31 | 12.82 | 12.70 |
| 2022-12-31 | 4.67 | 4.63 |
| 2022-09-30 | -4.69 | -4.70 |
| 2022-06-30 | -2.75 | -2.75 |
| 2022-03-31 | 1.23 | 1.21 |
| 2021-12-31 | 12.53 | 12.40 |
| 2021-09-30 | 16.01 | 15.86 |
| 2021-06-30 | 16.11 | 15.97 |
| 2021-03-31 | 13.46 | 13.34 |
| 2020-12-31 | 18.78 | 18.59 |
| 2020-09-30 | -21.47 | -21.46 |
| 2020-06-30 | -14.02 | -14.02 |
| 2020-03-31 | -4.32 | -4.32 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Nxera Pharma Co., Ltd. per 2025 Jun 30 adalah -8,796.00 MM.
- Nilai cash from investing activities untuk Nxera Pharma Co., Ltd. per 2025 Jun 30 adalah -1,682.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Nxera Pharma Co., Ltd. per 2025 Jun 30 adalah -6,706.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -8,796.00 | -1,682.00 | -6,706.00 |
| 2025-03-31 | -4,900.00 | -1,116.00 | -6,703.00 |
| 2024-12-31 | -7,718.00 | -4,763.00 | -6,854.00 |
| 2024-09-30 | 2,425.00 | -669.00 | 3,553.00 |
| 2024-06-30 | -782.00 | -61,605.00 | 44,938.00 |
| 2024-03-31 | -6,321.00 | -63,711.00 | 46,556.00 |
| 2023-12-31 | -5,273.00 | -63,791.00 | 48,329.00 |
| 2023-09-30 | 653.00 | -61,834.00 | 39,543.00 |
| 2023-06-30 | 10,153.00 | -526.00 | -213.00 |
| 2023-03-31 | 10,386.00 | 1,003.00 | -4,892.00 |
| 2022-12-31 | 9,952.00 | 1,043.00 | -4,887.00 |
| 2022-09-30 | 14,836.00 | -165.00 | -4,902.00 |
| 2022-06-30 | 5,389.00 | -315.00 | 5,891.00 |
| 2022-03-31 | 6,394.00 | 250.00 | 10,880.00 |
| 2021-12-31 | 7,095.00 | 278.00 | 11,123.00 |
| 2021-09-30 | -448.00 | 338.00 | 10,791.00 |
| 2021-06-30 | 2,140.00 | 647.00 | 20,877.00 |
| 2021-03-31 | 2,313.00 | -410.00 | 20,686.00 |
| 2020-12-31 | 4,672.00 | -150.00 | 20,278.00 |
| 2020-09-30 | 1,441.00 | -140.00 | 15,788.00 |
| 2020-06-30 | |||
| 2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | |||
| 2020-09-30 | |||
| 2020-06-30 | |||
| 2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 | ||
| 2020-09-30 | ||
| 2020-06-30 | ||
| 2020-03-31 |
Efektivitas Manajemen
- roa untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.01.
- roe untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.03.
- roic untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.02.
- croic untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.09.
- ocroic untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.04.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | -0.01 | -0.03 | -0.02 | -0.09 | -0.04 |
| 2025-03-31 | -0.03 | -0.07 | -0.04 | -0.12 | -0.06 |
| 2024-12-31 | -0.02 | -0.06 | -0.03 | 0.05 | 0.02 |
| 2024-09-30 | -0.07 | -0.17 | -0.07 | -0.10 | -0.01 |
| 2024-06-30 | -0.16 | ||||
| 2024-03-31 | -0.12 | ||||
| 2023-12-31 | -0.05 | -0.30 | |||
| 2023-09-30 | 0.03 | 0.18 | |||
| 2023-06-30 | 0.03 | ||||
| 2023-03-31 | 0.02 | ||||
| 2022-12-31 | |||||
| 2022-09-30 | 0.00 | ||||
| 2022-06-30 | -0.01 | -0.01 | |||
| 2022-03-31 | 0.00 | ||||
| 2021-12-31 | 0.00 | ||||
| 2021-09-30 | 0.02 | 0.03 | |||
| 2021-06-30 | 0.03 | 0.02 | 0.35 | 0.03 | |
| 2021-03-31 | 0.02 | 0.03 | 0.01 | 0.34 | 0.03 |
| 2020-12-31 | 0.03 | 0.03 | 0.02 | 0.36 | 0.07 |
| 2020-09-30 | -0.03 | -0.04 | -0.03 | 0.26 | 0.02 |
| 2020-06-30 | -0.02 | -0.03 | -0.02 | -0.04 | 0.10 |
| 2020-03-31 | -0.01 | -0.01 | -0.01 | -0.05 | 0.10 |
Gross Margins
- marjin kotor untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.74.
- marjin bersih untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.08.
- marjin operasi untuk Nxera Pharma Co., Ltd. pada 2025 Jun 30 adalah -0.15.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | 0.74 | -0.08 | -0.15 |
| 2025-03-31 | 0.74 | -0.17 | -0.19 |
| 2024-12-31 | 0.81 | -0.13 | -0.04 |
| 2024-09-30 | 0.80 | -0.42 | -0.25 |
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | 0.12 | 0.20 | |
| 2023-06-30 | 0.12 | 0.20 | |
| 2023-03-31 | 0.07 | 0.24 | |
| 2022-12-31 | |||
| 2022-09-30 | 0.00 | 0.00 | |
| 2022-06-30 | -0.04 | 0.00 | |
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | 0.91 | 0.14 | 0.02 |
| 2021-03-31 | 0.91 | 0.12 | 0.02 |
| 2020-12-31 | 0.91 | 0.17 | 0.10 |
| 2020-09-30 | 0.88 | -0.26 | -0.21 |
| 2020-06-30 | 0.89 | -0.15 | -0.13 |
| 2020-03-31 | 0.90 | -0.04 | -0.07 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
